Unexplained weight loss (UWL), clinically defined as a loss of more than 5% of body weight within a 6-12 month period without a known cause, can be a diagnostic challenge for physicians. It is often a manifestation of underlying serious conditions, requiring a comprehensive and systematic approach for effective management.
A thorough history taking and physical examination is the cornerstone of the initial evaluation. It is crucial to identify any changes in appetite, dietary habits, psychiatric symptoms, or medications that may contribute to weight loss. The physical examination should focus on signs of malnutrition, wasting syndromes, and systemic diseases.
Basic laboratory tests, including complete blood count, comprehensive metabolic panel, thyroid function tests, and inflammatory markers, are recommended in the initial workup. If these tests are inconclusive, advanced diagnostic tools such as imaging studies, endoscopies, or biopsies may be necessary.
Once the underlying cause is identified, management should be condition-specific and patient-centered. In cases where no cause is found, symptomatic management with nutritional support and appetite stimulants can be beneficial. Regular follow-up is essential to monitor the patient's progress and adjust treatment plans accordingly.
Unexplained weight loss is a complex clinical problem that requires a comprehensive approach for effective evaluation and management. A systematic and methodical approach can help identify the underlying cause, enabling appropriate, timely interventions. It is essential to remember that despite exhaustive investigations, a cause may not always be found, and symptomatic management becomes crucial.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation